Gracell Biotechnologies Dividend
Dividend criteria checks 0/6
Gracell Biotechnologies does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$5.14 |
Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
AstraZeneca Deal For Gracell Biotechnologies Closing Tomorrow (Includes CVR)
Feb 21Gracell Biotechnologies initiated at buy at Citi citing its autologous CAR-T platform
Sep 22Gracell Biotechnologies GAAP EPS of -$0.06 beats by $0.02
Aug 15Gracell Biotechnologies rallies after naming new chief medical officer
Aug 01Gracell names Dr. Samuel Zhang as Chief Business Officer
Jul 19Gracell Bio Shares Tumble As Investors Blow Hot, Cold Over Its Cutting-Edge Cancer Treatment
Nov 26Gracell ends IPO quiet period with favorable views from analysts
Feb 02Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if GRCL's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if GRCL's dividend payments have been increasing.
Dividend Yield vs Market
Gracell Biotechnologies Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (GRCL) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (GRCL) | 0% |
Notable Dividend: Unable to evaluate GRCL's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate GRCL's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate GRCL's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as GRCL has not reported any payouts.